Drug Utilization Management Continues To Rise On Part D Formularies, MedPAC Says
This article was originally published in The Pink Sheet Daily
Nearly one-third of chemical entities on Medicare Part D prescription drug plan formularies face some kind of utilization management in 2010, MedPAC reports.
You may also be interested in...
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.